Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index; 19 of the 30 sources its claims cite were checked for support.
Abstract
The inherited peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), associated with neurodegeneration and inflammatory cerebral demyelination, is caused by mutations in the ABCD1 gene encoding the peroxisomal ATP-binding cassette (ABC) transporter ABCD1 (ALDP). ABCD1 transports CoA-esters of very long-chain fatty acids (VLCFA) into peroxisomes for degradation by β-oxidation; thus, ABCD1 deficiency results in VLCFA accumulation. The closest homologue, ABCD2 (ALDRP), when overexpressed, compensates for ABCD1 deficiency in X-ALD fibroblasts and in Abcd1-deficient mice. Microglia/macrophages have emerged as important players in the progression of neuroinflammation. Human monocytes, lacking significant expression of ABCD2, display severely impaired VLCFA metabolism in X-ALD. Here, we used thioglycollate-elicited primary mouse peritoneal macrophages (MPMΦ) from Abcd1 and Abcd2 single- and double-deficient mice to establish how these mutations affect VLCFA metabolism. By quantitative RT-PCR, Abcd2 mRNA was about half as abundant as Abcd1 mRNA in wild-type and similarly abundant in Abcd1-deficient MPMΦ. VLCFA (C26∶0) accumulated about twofold in Abcd1-deficient MPMΦ compared with wild-type controls, as measured by gas chromatography-mass spectrometry. In Abcd2-deficient macrophages VLCFA levels were normal. However, upon Abcd1/Abcd2 double-deficiency, VLCFA accumulation was markedly increased (sixfold) compared with Abcd1-deficient MPMΦ. Elovl1 mRNA, encoding the rate-limiting enzyme for elongation of VLCFA, was equally abundant across all genotypes. Peroxisomal β-oxidation of C26∶0 amounted to 62% of wild-type activity in Abcd1-deficient MPMΦ and was significantly more impaired (29% residual activity) upon Abcd1/Abcd2 double-deficiency. Single Abcd2 deficiency did not significantly compromise β-oxidation of C26∶0. Thus, the striking accumulation of VLCFA in double-deficient MPMΦ compared with single Abcd1 deficiency was due to the loss of ABCD2-mediated, compensatory transport of VLCFA into peroxisomes. We propose that moderate endogenous expression of Abcd2 in Abcd1-deficient murine macrophages prevents the severe metabolic phenotype observed in human X-ALD monocytes, which lack appreciable expression of ABCD2. This supports upregulation of ABCD2 as a therapeutic concept in X-ALD.
Overview
CoChat Summary
TL;DR
In Abcd1-deficient mouse peritoneal macrophages, endogenous Abcd2 expression at about half the level of Abcd1 substantially compensates for loss of ABCD1, limiting VLCFA accumulation and preserving peroxisomal β-oxidation. Combined Abcd1/Abcd2 deficiency causes a much more severe metabolic phenotype, supporting ABCD2 upregulation as a therapeutic concept in X-linked adrenoleukodystrophy.
Key findings
- In wild-type mouse peritoneal macrophages, Abcd2 mRNA was present at 58% of Abcd1 mRNA; Abcd2 mRNA levels were not significantly changed in Abcd1-deficient macrophages.
- C26:0 accumulated about twofold in Abcd1-deficient macrophages versus wild-type, but was normal in Abcd2-deficient macrophages; Abcd1/Abcd2 double deficiency increased C26:0 accumulation sixfold compared with Abcd1 deficiency alone, or about twelvefold versus wild-type.
- Peroxisomal β-oxidation of C26:0 was 62% of wild-type activity in Abcd1-deficient macrophages and fell to 29% residual activity in Abcd1/Abcd2 double-deficient macrophages; single Abcd2 deficiency did not significantly impair C26:0 β-oxidation.
- Elovl1 mRNA was equally abundant across all genotypes, and C16:0 β-oxidation was similar across genotypes, suggesting the double-deficiency phenotype was due mainly to loss of ABCD2-mediated compensatory VLCFA transport into peroxisomes.
Methods
- Abcd2-deficient mice were generated by targeted inactivation and crossed with Abcd1-deficient mice on the C57BL/6J background; adult 3–6-month-old male mice were used to isolate thioglycollate-elicited primary mouse peritoneal macrophages.
- mRNA levels for Abcd1, Abcd2, and Elovl1 were measured by quantitative RT-PCR and normalized to Hprt; VLCFA species C26:0, C24:0, C22:0, and C16:0 were measured by GC-MS.
- Peroxisomal β-oxidation was assayed using 1-14C-labelled C26:0 and C16:0; statistical analyses used t-tests or one-way ANOVA with post-hoc tests, with significance at p<0.05.
Limitations
- The authors state that the findings cannot be directly translated to human perivascular or parenchymal macrophages or activated microglia in X-ALD brain lesions, and that species differences may contribute to the lack of cerebral inflammatory phenotype in mouse models.
- The authors note they cannot exclude altered ELOVL1 enzymatic activity or substrate availability, although they consider a major contribution unlikely given the impaired VLCFA degradation.
- Evident from the text: many experiments used n=3, only male mice were studied, and thioglycollate-elicited peritoneal macrophages may differ from resident macrophages or microglia; the paper also notes possible eosinophil contamination in such preparations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
13 Valid · 1 Not valid · 8 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast to primary mouse peritoneal macrophages, primary human monocytes/macrophages virtually lack ABCD2 gene expression [40], [41].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Could not verifycites [40] T Langmann, 2006, Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation, Clin Chem sourceExperimental — accuracy not yet measured
The Results say that 30 ABC transporters had detectable mRNA in human primary monocytes and refer to Table 1, but the passages available from our copy do not identify ABCD2 as expressed or unexpressed. Searches for ABCD2 and for its absence in monocytes/macrophages found no gene-specific result; the Table 1 passage contains only its caption and notes. (LLM, conf=0.72)
- Supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet source
The Results section reports that ABCD2 mRNA was barely detectable in primary human monocytes (Fig. 1A). The Discussion adds that differentiation of monocytes into macrophages did not change this status: ABCD2 expression remained below the level defined as expressed. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in contrast to human monocytes [41] or human fibroblasts [7], in the absence of ABCD1, sufficient amounts of endogenous ABCD2 are present to maintain a substantial β-oxidation capacity for VLCFA substrates (62% of wild-type β-oxidation activity for C26∶0, Fig. 5).”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet source
The citation [41] supports the contrast with human monocytes, not the subsequent result for murine macrophages. The Discussion reports that ABCD2 is barely expressed in monocytes and that C26:0 β-oxidation in X-ALD monocytes is reduced to less than 30% of control values. The 62% figure is presented as the citing paper’s Fig. 5 result, not as a finding attributed to this source. (LLM, conf=0.93)
- Supportedcites [7] C Wiesinger, 2013, Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction, J Biol Chem source
The citation [7] is attached to the contrast with human fibroblasts, not to the murine macrophage result or the 62% figure. The Discussion states that ABCD2 is virtually absent in human fibroblasts and that they show a pronounced VLCFA β-oxidation deficit. The murine percentage is presented as the citing paper’s own Fig. 5 result. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, we obtained evidence showing that the feasibility to induce ABCD2 depends on the differentiation state in the human monocyte/macrophage lineage [66].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [66] FD Weber, 2014, Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy, PLoS ONE source
The Results section reports that 13CRA induced ABCD2 in differentiated human monocyte-derived macrophages. The Discussion contrasts this with unchanged ABCD2 levels in primary monocytes from 13CRA-treated patients, supporting the claim that inducibility differs with differentiation state. The comparison involves different treatment settings, so it does not isolate differentiation as the cause. (LLM, conf=0.87)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Compared with wild-type levels, we found a two-fold increase in the ratio C26∶0/C22∶0 (Fig. 3A).”
- Also stated in: § Discussion · plain
“Our results revealed about twofold higher levels of VLCFA in Abcd1-deficient MPMΦ, as judged by the ratio C26∶0/C22∶0, in agreement with previous observations [27].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Results > Inactivation of Abcd2 alone has no impact on VLCFA levels of MPMΦ but a strong synergistic effect in combined Abcd1/Abcd2 deficiency
What the sources say
- Partly supportedcites [27] N Yanagisawa, 2008, Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages, Lipids Health Dis sourceExperimental — accuracy not yet measured
The Results section, “Quantification of C26:0” (page unavailable), reports that the C26:0/C22:0 ratio in macrophages from ALDP-deficient mice was significantly higher than in wild-type mice. Our copy does not give a numerical ratio or establish the claimed two-fold increase. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The most likely candidate for mediating the residual β-oxidation activity (29%) for C26∶0 in the Abcd1/Abcd2 double-deficient MPMΦ is the third peroxisomal ABC transporter, ABCD3, in similarity to human X-ALD fibroblasts [7] and monocytes [41].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [7] C Wiesinger, 2013, Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction, J Biol Chem source
The Discussion states that ABCD3 is responsible for most residual VLCFA β-oxidation in human X-ALD fibroblasts, supporting the fibroblast comparison for which this source is cited. The mouse macrophage result and monocyte comparison are not attributed to this citation. (LLM, conf=0.92)
- Partly supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
39 more claims · 2 with their cited sources checked
Create a free account to see all 73 claims and every source verdict.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is intriguing that also Abcd1/Abcd2 double-deficient mice do not develop brain inflammation or demyelination [156], in spite of the finding that Abcd1/Abcd2 double-deficient peritoneal macrophages are metabolically much more severely affected than those from single transporter-deficient mice [157]. Also in these mice, the neuropathology is restricted mainly to axonopathy in the spinal cord and,”
From Peroxisomes in brain development and function (2016) · cites this paper as [157]
The cited source says what the claim attributes to it.
In the citing paper
“Upon overexpression, ABCD2101–104 and, to some extent, ABCD35,102,105 can compensate for the lack of ABCD1 in vivo and in vitro, and therefore represent excellent candidates for a modulation of the phenotype.”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Materials and Methods > Construction of the Abcd2 targeting vector
“a 2.1-kb NdeI− SphI fragment (−2.5 kb to −422 relative to the translation start site of Abcd2) representing the 5′ (short) Abcd2 homology region”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Results > Targeted inactivation of the murine Abcd2 gene
“Between the “short arm” (3.5 kb of DNA upstream from exon 1) and the “long arm” (6 kb from the 3′ end of exon 1 through intron 3) of the targeting vector”
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“Protein concentration was determined by the method of Lowry using bovine serum albumin (Sigma-Aldrich) as standard [56].”
MethodSingle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA was isolated from flash frozen tissues [53] of 2.”
MethodDerivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“Mouse RI embryonic stem (ES) cells [51], kindly provided by A.”
BackgroundMansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“from wild-type and knock-out mice as described in [55] with some”
MethodHematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“Allogeneic bone marrow transplantation or hematopoietic stem cell transplantation [36,37] and also gene therapy of autologous CD34 hematopoietic stem cells, providing intact ABCD1, can arrest the inflammatory cerebral demyelination in patients at early stages of cerebral ALD [38].”
BackgroundPutative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 1×
“Genome-wide transcriptome analysis indicates that thioglycollate-induced macrophages are closely related to microglial cells as well as to bone marrow derived macrophages [49].”
BackgroundFatty acid elongases in mammals: their regulation and roles in metabolism
JAKOBSSON, A., WESTERBERG, R., & JACOBSSON, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.01.004 · Cited by 936 · cited 2×
“long-chain fatty acids (ELOVL), mediates the substrate-selective step of the elongation pathway [12].”
BackgroundTwo physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689 · cited 1×
“These differ in size, surface markers and function from the residential peritoneal macrophages but show similar phagocytic activity [48].”
BackgroundThe Activation of Mononuclear Phagocytes: Fact, Fancy, and Future
Cohn, Z. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.3.813 · Cited by 601 · cited 1×
“In comparison to other sources of murine macrophages or microglia, large numbers of primary macrophages can be obtained from the peritoneal cavity after stimulation with thioglycollate [45,46], permitting biochemical studies of VLCFA metabolism in primary macrophages of targeted mouse mutants.”
BackgroundAdrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy
Moser, H. (1997) · Brain · doi:10.1093/brain/120.8.1485 · Cited by 478 · cited 1×
“clinical phenotypes of X-ALD in males [1–3].”
Assembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471 · cited 1×
“G418/gancyclovir selection as previously described [50,52].”
Moser, H. (1981) · doi:10.1212/wnl.31.10.1241 · Cited by 396
Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3402 · Cited by 374
Aubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366 · cited 1×
“Allogeneic bone marrow transplantation or hematopoietic stem cell transplantation [36,37] and also gene therapy of autologous CD34 hematopoietic stem cells, providing intact ABCD1, can arrest the inflammatory cerebral demyelination in patients at early stages of cerebral ALD [38].”
BackgroundForss-Petter, S., Danielson, P. E., Catsicas, S., Battenberg, E., Price, J., Nerenberg, M., & Sutcliffe, G. (1990) · Neuron · doi:10.1016/0896-6273(90)90308-3 · Cited by 365
Self-citationA mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · cited 1×
“The capacity for peroxisomal b-oxidation of saturated VLCFA is reduced in patients with X-ALD [14] as well as in Abcd1deficient mice [15–17].”
BackgroundX-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283 · cited 1×
“clinical phenotypes of X-ALD in males [1–3].”
Self-citationGene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D. (1998) · Nature Medicine · doi:10.1038/3242 · Cited by 249
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238 · cited 1×
“Interestingly, in the perilesional white matter surrounding demyelinating brain lesions in cerebral ALD, microglia, the resident macrophages of the brain, are particularly vulnerable to neurotoxicity and apoptosis [42], as reviewed in [43].”
BackgroundSelf-citationSingh, I., Moser, A. E., Moser, H. W., & Kishimoto, Y. (1984) · Pediatric Research · doi:10.1203/00006450-198403000-00016 · Cited by 234 · cited 1×
“The capacity for peroxisomal b-oxidation of saturated VLCFA is reduced in patients with X-ALD [14] as well as in Abcd1deficient mice [15–17].”
BackgroundX-linked adrenoleukodystrophy in women: A cross-sectional cohort study
Engelen, M., Barbier, M., Dijkstra, I. M. E., Schür, R., de Bie, R. M. A., Verhamme, C., Dijkgraaf, M. G. W., Aubourg, P. A., Wanders, R. J. A., van Geel, B. M., et al. (2014) · Brain · doi:10.1093/brain/awt361 · Cited by 234
Lombard-Platet, G., Savary, S., Sarde, C. O., Mandel, J. L., & Chimini, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1265 · Cited by 222 · cited 1×
“This deletion eliminates the transcription and translation start sites and the coding capacity for the 272 amino-terminal amino acids of ABCD2 [59].”
BackgroundEarly oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 6×
“Inactivation of Abcd2 alone has no significant effect on the levels of saturated VLCFA in most murine tissues including brain, spinal cord and sciatic nerve, which are affected by the pathology in X-ALD [31], which is also the case in our Abcd2 mouse strain (Forss-Petter, unpublished observation).”
BackgroundInfluentialHo, J. K., Moser, H., Kishimoto, Y., & Hamilton, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118182 · Cited by 199 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundX-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects
Berger, J., & Gärtner, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.010 · Cited by 199 · cited 1×
“clinical phenotypes of X-ALD in males [1–3].”
Self-citationKobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197 · cited 1×
“The capacity for peroxisomal b-oxidation of saturated VLCFA is reduced in patients with X-ALD [14] as well as in Abcd1deficient mice [15–17].”
BackgroundIs microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?
Eichler, F. S., Ren, J., Cossoy, M., Rietsch, A. M., Nagpal, S., Moser, A. B., Frosch, M. P., & Ransohoff, R. M. (2008) · Annals of Neurology · doi:10.1002/ana.21391 · Cited by 178 · cited 2×
“Interestingly, in the perilesional white matter surrounding demyelinating brain lesions in cerebral ALD, microglia, the resident macrophages of the brain, are particularly vulnerable to neurotoxicity and apoptosis [42], as reviewed in [43].”
BackgroundThe role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170
Cartier, N., & Aubourg, P. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00394.x · Cited by 151 · cited 1×
“The beneficial effects observed upon transplantation and gene therapy of CD34 hematopoietic stem cells suggest an involvement of the bone marrow-derived macrophages and microglia in this process [39].”
BackgroundNetik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148 · cited 1×
“Overexpression of ABCD2 has been shown to functionally compensate for the impairment in peroxisomal boxidation and VLCFA accumulation resulting from ABCD1 deficiency in human X-ALD fibroblasts and in Abcd1-deficient mice [29–31].”
BackgroundSelf-citationRole of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147 · cited 1×
“This is similar to the extent of VLCFA storage in modestly affected tissues like the liver of X-ALD mice [63].”
BackgroundWiesinger, C., Kunze, M., Regelsberger, G., Forss-Petter, S., & Berger, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445445 · Cited by 145
Self-citationAdreno-leukodystrophy: Oxidative Stress of Mice and Men
Powers, J. M., Pei, Z., Heinzer, A. K., Deering, R., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000190064.28559.a4 · Cited by 129
Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation
van Roermund, C. W. T., Visser, W. F., IJlst, L., Waterham, H. R., & Wanders, R. J. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.010 · Cited by 128 · cited 5×
“However, little is known about the endogenous capacity for cross-compensation between ABCD1 and ABCD2 under conditions of insufficiency in vivo.”
BackgroundInfluentialLópez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundBiochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116 · cited 1×
“Moreover, the accumulating VLCFA can serve as substrates for ELOVL1, which promotes further increase in chain length and amount of VLCFA culminating with peak levels of C26:0 [13,18].”
BackgroundHUBBARD, W., MOSER, A., TORTORELLI, S., LIU, A., JONES, D., & MOSER, H. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.001 · Cited by 108 · cited 1×
“Furthermore, in X-ALD, VLCFA were found to be enriched in the lysophosphatidylcholine (LPC) fraction [44]; and C24:0-containing LPC elicited microglial activation and apoptosis when injected into the cerebral cortex of mice [42].”
BackgroundBerger, J., Albet, S., Bentejac, M., Netik, A., Holzinger, A., Roscher, A. A., Bugaut, M., & Forss‐Petter, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00772.x · Cited by 106 · cited 2×
“Loss of Abcd2 mRNA expression in gene targeted mice To verify that homologous recombination had inactivated functional expression of Abcd2, we assessed the presence of Abcd2 mRNA by Northern blot analysis in brain and skeletal muscle, two tissues in which Abcd2 is normally abundantly expressed [60].”
BackgroundSelf-citationFerrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106 · cited 3×
“In Abcd2-deficient mice, saturated VLCFA do not generally accumulate; increased C26:0 levels have been detected exclusively in the dorsal root ganglia of young Abcd2-deficient mice [33].”
BackgroundA key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
Fourcade, S., Ruiz, M., Camps, C., Schlüter, A., Houten, S. M., Mooyer, P. A. W., Pàmpols, T., Dacremont, G., Wanders, R. J. A., Giròs, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90736.2008 · Cited by 104 · cited 1×
“In other tissues, like spinal cord, the abundance of these fatty acids was normal; and in Abcd1/Abcd2-double deficient mice only the level of C22:1v9 was elevated compared with Abcd1 and Abcd2 single deficient mice [34].”
BackgroundA role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids
van Roermund, C. W. T., IJlst, L., Wagemans, T., Wanders, R. J. A., & Waterham, H. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.001 · Cited by 101 · cited 1×
“preferred substrates for human ABCD3 in a heterologous expression system, while low activity was obtained with C26:0 [64].”
BackgroundElongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy
Kemp, S., Valianpour, F., Denis, S., Ofman, R., Sanders, R.-J., Mooyer, P., Barth, P. G., & Wanders, R. J. A. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.015 · Cited by 97 · cited 1×
“human X-ALD patients [9,10] with only a minor contribution”
BackgroundKnazek, R. A., Rizzo, W. B., Schulman, J. D., & Dave, J. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110963 · Cited by 94 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundHolzinger, A., Kammerer, S., Berger, J., & Roscher, A. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7391 · Cited by 92 · cited 1×
“Another peroxisomal ATP-binding cassette (ABC) transporter, ABCD2 (formerly adrenoleukodystrophy-related protein, ALDRP), encoded by the ABCD2 gene, is the closest homologue of ABCD1 [28].”
BackgroundSelf-citationCurrent and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy
Berger, J., Pujol, A., Aubourg, P., & Forss‐Petter, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00393.x · Cited by 90 · cited 1×
“Currently, there is no curative therapy available for most XALD patients [35].”
BackgroundSelf-citationPeroxisomal fatty acid β-oxidation in HepG2 cells
Watkins, P. A., Ferrell, E. V., Pedersen, J. I., & Hoefler, G. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90419-j · Cited by 86 · cited 1×
“b-Oxidation of labelled fatty acids to acetate was carried out according to [58] with modifications as described previously [7].”
MethodTroffer-Charlier, N., Doerflinger, N., Metzger, E., Fouquet, F., Mandel, J.-L., & Aubourg, P. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80121-0 · Cited by 85 · cited 1×
“However, the additive but not amplified severity of the metabolic and behavioural deficits might be partially explained by the rather complementary expression patterns of these two peroxisomal ABC transporters [41,60,62].”
BackgroundGalino, J., Ruiz, M., Fourcade, S., Schlüter, A., López-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arumí, E., Andreu, A. L., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3877 · Cited by 85 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundEffect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages
Leijh, P. C., van Zwet, T. L., ter Kuile, M. N., & van Furth, R. (1984) · Infection and Immunity · doi:10.1128/iai.46.2.448-452.1984 · Cited by 81 · cited 1×
“In comparison to other sources of murine macrophages or microglia, large numbers of primary macrophages can be obtained from the peritoneal cavity after stimulation with thioglycollate [45,46], permitting biochemical studies of VLCFA metabolism in primary macrophages of targeted mouse mutants.”
BackgroundKishimoto, Y., Moser, H. W., Kawamura, N., Platt, M., Pallante, S. L., & Fenselau, C. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91182-1 · Cited by 79 · cited 1×
“from dietary sources [11].”
TSUJI, S., SANO, T., ARIGA, T., & MIYATAKE, T. (1981) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133578 · Cited by 73
Gilg, A. G., Singh, A. K., & Singh, I. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1063 · Cited by 66 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundWeber, F. D., Wiesinger, C., Forss-Petter, S., Regelsberger, G., Einwich, A., Weber, W. H. A., Kohler, W., Stockinger, H., & Berger, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt645 · Cited by 63 · cited 4×
“In contrast to primary mouse peritoneal macrophages, primary human monocytes/macrophages virtually lack ABCD2 gene expression [40,41].”
BackgroundResultInfluentialSelf-citationFatty Acid Composition of Human Myelin Proteolipid Protein in Peroxisomal Disorders
Bizzozero, O. A., Zuñiga, G., & Lees, M. B. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02003.x · Cited by 61 · cited 1×
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundLangmann, T., Mauerer, R., & Schmitz, G. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059774 · Cited by 49 · cited 2×
“In contrast to primary mouse peritoneal macrophages, primary human monocytes/macrophages virtually lack ABCD2 gene expression [40,41].”
BackgroundMisharin, A. V., Saber, R., & Perlman, H. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111560 · Cited by 38 · cited 1×
“In addition to macrophages, some eosinophils, which also express these surface markers, may be present [47].”
BackgroundX‐linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism
Weinhofer, I., Forss-Petter, S., Kunze, M., Žigman, M., & Berger, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.014 · Cited by 32 · cited 1×
“Because we had previously found Abcd2 mRNA expression to be altered in hepatic tissue of Abcd1-deficient mice [61], we determined the Abcd2 mRNA levels in Abcd1-deficient MPMW in order to uncover any potential compensatory dysregulation.”
BackgroundSelf-citationTsuji, S., Sano-Kawamura, T., Ariga, T., & Miyatake, T. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90074-7 · Cited by 31
Yanagisawa, N., Shimada, K., Miyazaki, T., Kume, A., Kitamura, Y., Sumiyoshi, K., Kiyanagi, T., Iesaki, T., Inoue, N., & Daida, H. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-48 · Cited by 29
Singh, J., Khan, M., & Singh, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.004 · Cited by 21 · cited 1×
“levels [65] indicating an association between VLCFA levels and the regulation of Elovl1 expression.”
BackgroundDiagnosis of X-linked adrenoleukodystrophy in blood leukocytes
Unterberger, U., Regelsberger, G., Sundt, R., Bernheimer, H., & Voigtländer, T. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.04.015 · Cited by 11 · cited 1×
“Extraction and quantitative analysis of fatty acids by gas chromatography-mass spectrometry (GC-MS) were carried out as previously described [57].”
MethodSelf-citationWeber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103742 · Cited by 8 · cited 2×
“Recently, we obtained evidence showing that the feasibility to induce ABCD2 depends on the differentiation state in the human monocyte/macrophage lineage [66].”
BackgroundSelf-citationKemp, S., Valianpour, F., Denis, S. W., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.018 · Cited by 1
Forss-Petter, S. (1997) · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w · cited 2×
“129-Abcd1) have been described previously [15].”
MethodSelf-citation
Research works printed but not linked: 1
- Van Roermund CW, Ijlst L, Wagemans T, Wanders RJ, Waterham HR (2013) A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochim Biophys Acta. · DOI · Paper page
Cited by
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
“It is intriguing that also Abcd1/Abcd2 double-deficient mice do not develop brain inflammation or demyelination [156], in spite of the finding that Abcd1/Abcd2 double-deficient peritoneal macrophages are metabolically much more severely affected than those from single transporterdeficientmice [157].”
BackgroundSelf-citationBerger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Self-citationPeroxisomes in Immune Response and Inflammation
Di Cara, F., Andreoletti, P., Trompier, D., Vejux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui-Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 128
“Consistently, a higher accumulation of VLCFA was shown in Abcd1/Abcd2 double-deficient mouse peritoneal macrophage, compared to the single Abcd1 deficiency [54].”
BackgroundBrain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
“MYC silencing mimic the effect of”
BackgroundFourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 76
Metadata
- Authors
- Muneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S.
- Affiliations
- Medical University of Vienna (AT)
- Max Planck Institute of Experimental Medicine (DE)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-25
- Volume
- 9
- Issue
- 9
- Pages
- e108655
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4177892
- OpenAlex
- W2095313254
- Cited by
- 33
- References
- 68
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1 · 2015: 5
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- European Commission (241622, FP7-HEALTH-2009)
- Austrian Science Fund (P26112, P26112-B19,)
- Higher Education Commision, Pakistan
- FP7 Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- X-linked adrenoleukodystrophy, ABCD1, ABCD2, very long chain fatty acids, peroxisomal beta-oxidation, peritoneal macrophages, ELOVL1, peroxisomal disorders, genetic modifiers, neuroinflammation
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Fatty Acid Elongases, Long-Chain-Fatty-Acid-CoA Ligase, Acetyltransferases, Animals, Coenzyme A Ligases, Fatty Acids, Gene Expression Regulation, Genetic Vectors, Male, Oxidation-Reduction, RNA, Messenger, Macrophages, Peritoneal, Mice, Knockout, Gene Targeting, ATP-Binding Cassette Transporters, Peroxisomes, Gene Silencing, Gene Order, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.